Anebulo Pharmaceuticals's total assets for Q2 2025 were $15.84M, an increase of 541.88% from the previous quarter. ANEB total liabilities were $878.80K for the fiscal quarter, a 54.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.